82 related articles for article (PubMed ID: 26942921)
21. Melatonin as an angiogenesis inhibitor to combat cancer: Mechanistic evidence.
Goradel NH; Asghari MH; Moloudizargari M; Negahdari B; Haghi-Aminjan H; Abdollahi M
Toxicol Appl Pharmacol; 2017 Nov; 335():56-63. PubMed ID: 28974455
[TBL] [Abstract][Full Text] [Related]
22. How does hypoxia inducible factor-1α participate in enhancing the glycolysis activity in cervical cancer?
Cheng Y; Chen G; Hong L; Zhou L; Hu M; Li B; Huang J; Xia L; Li C
Ann Diagn Pathol; 2013 Jun; 17(3):305-11. PubMed ID: 23375385
[TBL] [Abstract][Full Text] [Related]
23. Valproic acid inhibits the angiogenic potential of cervical cancer cells via HIF-1α/VEGF signals.
Zhao Y; You W; Zheng J; Chi Y; Tang W; Du R
Clin Transl Oncol; 2016 Nov; 18(11):1123-1130. PubMed ID: 26942921
[TBL] [Abstract][Full Text] [Related]
24. Ascochlorin inhibits growth factor-induced HIF-1α activation and tumor-angiogenesis through the suppression of EGFR/ERK/p70S6K signaling pathway in human cervical carcinoma cells.
Jeong JH; Jeong YJ; Cho HJ; Shin JM; Kang JH; Park KK; Park YY; Chung IK; Chang HW; Magae J
J Cell Biochem; 2012 Apr; 113(4):1302-13. PubMed ID: 22109717
[TBL] [Abstract][Full Text] [Related]
25. Chlorogenic acid inhibits hypoxia-induced angiogenesis via down-regulation of the HIF-1α/AKT pathway.
Park JJ; Hwang SJ; Park JH; Lee HJ
Cell Oncol (Dordr); 2015 Apr; 38(2):111-8. PubMed ID: 25561311
[TBL] [Abstract][Full Text] [Related]
26. (-)-Epigallocatechin-3-gallate inhibits human papillomavirus (HPV)-16 oncoprotein-induced angiogenesis in non-small cell lung cancer cells by targeting HIF-1α.
He L; Zhang E; Shi J; Li X; Zhou K; Zhang Q; Le AD; Tang X
Cancer Chemother Pharmacol; 2013 Mar; 71(3):713-25. PubMed ID: 23292117
[TBL] [Abstract][Full Text] [Related]
27. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
Chen MC; Lee CF; Huang WH; Chou TC
Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
[TBL] [Abstract][Full Text] [Related]
28. Delphinidin inhibits angiogenesis through the suppression of HIF-1α and VEGF expression in A549 lung cancer cells.
Kim MH; Jeong YJ; Cho HJ; Hoe HS; Park KK; Park YY; Choi YH; Kim CH; Chang HW; Park YJ; Chung IK; Chang YC
Oncol Rep; 2017 Feb; 37(2):777-784. PubMed ID: 27959445
[TBL] [Abstract][Full Text] [Related]
29. Valproic acid inhibits proliferation of HER2-expressing breast cancer cells by inducing cell cycle arrest and apoptosis through Hsp70 acetylation.
Mawatari T; Ninomiya I; Inokuchi M; Harada S; Hayashi H; Oyama K; Makino I; Nakagawara H; Miyashita T; Tajima H; Takamura H; Fushida S; Ohta T
Int J Oncol; 2015 Dec; 47(6):2073-81. PubMed ID: 26497673
[TBL] [Abstract][Full Text] [Related]
30. Histone deacetylase inhibitors and cell death.
Zhang J; Zhong Q
Cell Mol Life Sci; 2014 Oct; 71(20):3885-901. PubMed ID: 24898083
[TBL] [Abstract][Full Text] [Related]
31. Involvement of activating ERK1/2 through G protein coupled receptor 30 and estrogen receptor α/β in low doses of bisphenol A promoting growth of Sertoli TM4 cells.
Ge LC; Chen ZJ; Liu HY; Zhang KS; Liu H; Huang HB; Zhang G; Wong CK; Giesy JP; Du J; Wang HS
Toxicol Lett; 2014 Apr; 226(1):81-9. PubMed ID: 24495410
[TBL] [Abstract][Full Text] [Related]
32. VPA inhibits renal cancer cell migration by targeting HDAC2 and down-regulating HIF-1α.
Yang FQ; Liu M; Yang FP; Che J; Li W; Zhai W; Wang GC; Zheng JH; Li X
Mol Biol Rep; 2014 Mar; 41(3):1511-8. PubMed ID: 24390319
[TBL] [Abstract][Full Text] [Related]
33. Valproic acid inhibits tumor angiogenesis in mice transplanted with Kasumi‑1 leukemia cells.
Zhang ZH; Hao CL; Liu P; Tian X; Wang LH; Zhao L; Zhu CM
Mol Med Rep; 2014 Feb; 9(2):443-9. PubMed ID: 24297248
[TBL] [Abstract][Full Text] [Related]
34. Inhibitory effect of valproic acid on bladder cancer in combination with chemotherapeutic agents
Wang D; Jing Y; Ouyang S; Liu B; Zhu T; Niu H; Tian Y
Oncol Lett; 2013 Nov; 6(5):1492-1498. PubMed ID: 24179547
[TBL] [Abstract][Full Text] [Related]
35. Valproic acid treatment inhibits hypoxia-inducible factor 1α accumulation and protects against burn-induced gut barrier dysfunction in a rodent model.
Luo HM; Du MH; Lin ZL; Zhang L; Ma L; Wang H; Yu W; Lv Y; Lu JY; Pi YL; Hu S; Sheng ZY
PLoS One; 2013; 8(10):e77523. PubMed ID: 24147016
[TBL] [Abstract][Full Text] [Related]
36. Gene expression-based prediction of myeloma cell sensitivity to histone deacetylase inhibitors.
Moreaux J; Reme T; Leonard W; Veyrune JL; Requirand G; Goldschmidt H; Hose D; Klein B
Br J Cancer; 2013 Aug; 109(3):676-85. PubMed ID: 23868005
[TBL] [Abstract][Full Text] [Related]
37. Enhanced suppression of proliferation and migration in highly-metastatic lung cancer cells by combination of valproic acid and coumarin-3-carboxylic acid and its molecular mechanisms of action.
Liu X; Chen L; Sun F; Zhang G
Cytotechnology; 2013 Aug; 65(4):597-608. PubMed ID: 23161221
[TBL] [Abstract][Full Text] [Related]
38. Effects of valproic acid on proliferation, apoptosis, angiogenesis and metastasis of ovarian cancer in vitro and in vivo.
Shan Z; Feng-Nian R; Jie G; Ting Z
Asian Pac J Cancer Prev; 2012; 13(8):3977-82. PubMed ID: 23098503
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
